Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Oesophageal cancer and the suspected-cancer pathway

Gastroenterology and hepatology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Complete or rapidly progressive obstruction with inability to swallow saliva, aspiration, an impacted food bolus, haematemesis, severe chest pain after vomiting or instrumentation, and suspected perforation require same-day emergency assessment rather than routine pathway referral. Keep the patient nil by mouth when obstruction or perforation is possible, stabilise airway and circulation, and involve upper-GI surgery, gastroenterology, anaesthesia and radiology according to the presentation. Do not push food or tablets through a suspected malignant stricture.

Synopsis

Recognise oesophageal cancer promptly, use the current UK suspected-cancer pathway without diluting dysphagia as a red flag, and understand how endoscopy, staging, nutrition and multidisciplinary treatment fit together.

  • NICE recommends a suspected-cancer pathway referral for dysphagia at any adult age; a trial of acid suppression must not postpone that referral.
  • People aged 55 or over with weight loss plus upper abdominal pain, reflux or dyspepsia also meet the oesophageal or stomach cancer referral threshold.
  • Progression from difficulty with solids to difficulty with liquids suggests mechanical narrowing, although advanced dysmotility and benign strictures remain important differentials.
  • Upper-GI endoscopy defines the lesion and provides histology; biopsy technique and lesion description should support treatment planning rather than merely record a narrowed lumen.
  • Squamous-cell carcinoma and adenocarcinoma differ in distribution, risk pattern and treatment options, so histological subtype and exact relationship to the gastro-oesophageal junction matter.
  • Potentially curative disease is staged through an oesophago-gastric MDT using cross-sectional imaging, PET-CT and selective EUS or laparoscopy according to the clinical question.
  • Malnutrition and sarcopenia are common at diagnosis; swallowing safety and dietetic intervention should begin during staging, not after a final treatment decision.
  • Endoscopic resection can cure carefully staged superficial neoplasia, while more advanced local disease may require surgery, chemotherapy, chemoradiotherapy or a definitive non-operative strategy.

Key red flags

Progressive dysphagia

New food sticking, prolonged mealtimes or avoidance of meat and bread may precede obvious liquid dysphagia. Ask where food seems to stick, but remember that perceived level does not reliably locate the lesion.

Regurgitation and aspiration

Nocturnal regurgitation, coughing after swallowing, recurrent chest infection or a wet voice can reflect proximal pooling above an obstruction. Inability to manage saliva is an acute obstruction warning.

Investigation priorities

01
Upper-GI endoscopy with biopsyFirst step

Visualise the obstruction, define its extent and obtain diagnostic histology.

Management branches

ReferUse the cancer pathway promptly

An adult reports dysphagia, or a person aged 55 or over has weight loss with upper abdominal pain, reflux or dyspepsia.

  1. Clarify progression, intake, weight, aspiration, bleeding and performance status, examine for metastatic signs, and submit a suspected-cancer referral using the applicable devolved-nation or local route.
  2. Safety-net immediate deterioration, particularly inability to swallow saliva, food-bolus obstruction, haematemesis or severe chest pain, because these features require acute assessment rather than waiting for an appointment.
  3. Do not substitute empirical PPI treatment, a normal plain radiograph or an old benign endoscopy for current investigation of a new qualifying symptom.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG12: Suspected cancer recognition and referralCurrent symptom and age combinations for oesophageal and stomach suspected-cancer pathways.
  • NICE NG83: Oesophago-gastric cancer assessment and managementNational staging, radical treatment, obstruction, palliative and nutritional recommendations, including the 2023 obstruction update.
  • BSG and AUGIS upper-GI endoscopy quality standardsUK standards for complete mucosal inspection, lesion recognition, reporting and early upper-GI cancer diagnosis.
  • NICE CG32: Nutrition support for adultsAssessment, enteral and parenteral support, monitoring and refeeding-risk safeguards.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom